Table 3.
Characteristics of the patient group
| Variable | All geocoded patients (N = 6519) | Warfarin (N = 4560) | DOACs (N = 1239) | No medication (N = 720) |
|---|---|---|---|---|
| Age, mean (SD) | 76.5 (10.5) | 78.1 (9.4) | 75.1 (10.1) | 68.5 (13.5) |
| Retired, age ≥ 63 years, n (%) | 5896 (90.5) | 4302 (94.3) | 1103 (89.0) | 491 (68.2) |
| Gender, male, n (%) | 3532 (54.2) | 2388 (52.4) | 663 (53.5) | 481 (66.8) |
| BMI, mean (SD) | 29.1 (6.2) | 29.3 (6.4) | 29.3 (5.8) | 28.1 (5.4) |
| Obesity (BMI > 30), n (%) | 1456 (22.3) | 1006 (22.1) | 327 (26.4) | 123 (17.1) |
| CHA2DS2-VASc, mean (SD)a | 3.1 (1.6) | 3.3 (1.5) | 3.1 (1.6) | 1.9 (1.6) |
| Diabetes, n (%) | 1648 (25.3) | 1210 (26.5) | 315 (25.4) | 123 (17.1) |
| Hypertension, n (%) | 3261 (50.0) | 2302 (50.5) | 696 (56.2) | 263 (36.5) |
| Vascular disease, n (%)b | 1657 (25.4) | 1219 (26.7) | 323 (26.1) | 115 (16.0) |
| Congestive heart failure, n (%) | 976 (15.0) | 771 (16.9) | 161 (13.0) | 44 (6.1) |
| Transient ischemic attack (TIA), n (%) | 271 (4.2) | 188 (4.1) | 73 (5.9) | 10 (1.4) |
| Home address in assisted living building, n (%) | 765 (11.7) | 599 (13.1) | 93 (7.5) | 73 (10.1) |
| Number of INR measurements in 2017, mean (SD) | 15.4 (11.0) | 15.9 (10.9) | ||
| Standard TTR definable in 2017, n (%) | 3524 (54.1) | 3307 (72.5) |
aAnticoagulation medication should be used for patients having the score of 2 or more
bVascular disease includes the following ICD-10 codes: I20-I25, I70.9